GGrantIndex
← Search

Genomics

$93,012P30FY2016CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

PROJECT SUMMARY/ABSTRACT The Genomics Shared Resource (GSR) provides comprehensive services and expertise in the area of genomics and data analysis and bioinformatics. The GSR provides Cancer Center researchers with direct access to the most contemporary genomic applications and state-of-the-art instrumentation for next-generation sequencing (NGS), microarray analyses, and NanoString nCounter analyses. This includes Illumina NGS systems (MiSeq, HiSeq 2500, 3000, 4000), multi-platform microarray processing equipment for Affymetrix, Agilent, and Illumina microarrays, and the required computational hardware and software systems. Together, these enable investigators to accomplish virtually every type of application for transcriptomics, genome sequencing, epigenomics, and metagenomics, including whole transcriptome analysis, genome-wide profiling of single nucleotide variants, copy number analysis, mapping of long-range interactions of DNA regions, and molecular characterization of infectious agents. These are generally provided as completely comprehensive, sample-to-results services in that investigators need only provide RNA or DNA samples, and the GSR will perform all downstream technical processing, as well as data analysis. Ancillary services for DNA/RNA isolation, quality assessment, and sample acquisition are also provided. To complement these services and to help achieve productive outcomes from genomics experiments, the GSR provides extensive data analysis and integrative bioinformatics support, and routinely assists in the preparation of the appropriate sections of manuscripts and grant proposals. Additionally, education is an important component of the GSR and is provided through training, workshops, and seminars. Unique aspects of the GSR include a strong emphasis on facilitating translational science and the custom development of protocols and reagents to address the specific goals of investigators' experiments. For translational applications, the GSR has developed and optimized protocols enabling the analysis of samples obtained from clinical specimens, such as whole blood, serum/plasma, and FFPE specimens. Investigator-driven research often requires protocols and tools to be adapted or newly developed. These include modified sequencing library preparations and target enrichment panels for mutation screening of tumors and oncogenic viruses. Moreover, the GSR strives to introduce new technologies, such as single-cell sequencing and to serve as a pipeline for clinical applications of genomics. Taken together, the GSR provides a complete integrative and functional molecular profiling solution to the Cancer Center.

View original record on NIH RePORTER →